Competition between immune cells could explain why some immunotherapy drugs fail

Anne Li                                                                                               May 13th, 2017


New images may have uncovered why in some cases cancers don’t respond to certain immunotherapy drugs. Research published in the journal Science Translational Medicine found that, in mice, one type of immune cell competes with another by binding to the drug. The treatments – called checkpoint inhibitors – are targeted to the immune system’s T cells. But the research found that a different immune cell, called a macrophage, can snatch the drugs away, making them ineffective.
See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-05-12-competition-between-immune-cells-could-explain-why-some-immunotherapy-drugs-fail

Post a comment